InMode Ltd (INMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $763.61M
Last updated: Nov 17, 2026 at 11:06 AM ET
InMode Ltd (INMD) Financials: Revenue, Profit and Cash Flow
InMode reported revenue of $370.50M for the fiscal year ended Dec 31, 2025, down 6.2% from the year before. That year, net income was $93.83M with a net margin of 25.3%, operating cash flow was $85.26M and free cash flow was $84.28M. The quarter ended Sep 30, 2026 had revenue of $92.14M and net income of $18.86M.
Revenue and Margins
The operating margin was 23.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $23.08M, a compound annual rate of 36.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $370.50M | -6.2% | 78.5% | 23.0% | 25.3% |
| Dec 2024 | $394.82M | -19.8% | 80.3% | 28.5% | 45.9% |
| Dec 2023 | $492.05M | +8.3% | 83.6% | 39.8% | 40.2% |
| Dec 2022 | $454.27M | +27.0% | 83.8% | 43.6% | 35.6% |
| Dec 2021 | $357.56M | +73.5% | 85.0% | 46.8% | 46.1% |
| Dec 2020 | $206.11M | +31.8% | 85.0% | 35.3% | 36.4% |
| Dec 2019 | $156.36M | +56.1% | 87.1% | 38.1% | 39.1% |
| Dec 2018 | $100.16M | +87.4% | 85.0% | 23.5% | 22.3% |
| Dec 2017 | $53.46M | +131.6% | 83.1% | 16.7% | 16.5% |
| Dec 2016 | $23.08M | N/A | 75.5% | 2.9% | 1.5% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 48.2% from the year before. In the quarter ended Sep 2026, net income fell 13.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $370.50M | $394.82M | $492.05M | $454.27M | $357.56M | $206.11M | $156.36M | $100.16M | $53.46M | $23.08M |
| Cost of revenue | $79.53M | $77.75M | $80.71M | $73.48M | $53.59M | $30.85M | $20.24M | $15.06M | $9.05M | $5.65M |
| Gross profit | $290.97M | $317.07M | $411.34M | $380.79M | $303.97M | $175.26M | $136.12M | $85.11M | $44.40M | $17.43M |
| Research and development | $13.32M | $13.14M | $13.41M | $12.43M | $9.53M | $9.47M | $5.70M | $4.18M | $2.58M | $2.46M |
| Operating income | $85.39M | $112.53M | $195.66M | $197.85M | $167.48M | $72.84M | $59.62M | $23.49M | $8.95M | $669.00K |
| Net income | $93.83M | $181.28M | $197.92M | $161.52M | $164.97M | $75.03M | $61.15M | $22.37M | $8.82M | $336.00K |
| EBITDA | $111.03M | $144.20M | $217.89M | $202.15M | $168.52M | $73.26M | $59.92M | $31.67M | $9.15M | $820.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92.14M | $95.59M | $82.02M | $103.85M | $93.17M | $95.60M | $77.87M | $97.85M | $130.23M | $86.45M | $80.28M | $126.78M |
| Gross profit | $71.79M | $71.52M | $61.55M | $81.30M | $72.31M | $76.45M | $60.91M | $77.64M | $106.18M | $69.33M | $63.92M | $106.52M |
| Operating income | $17.51M | $12.26M | $10.06M | $25.99M | $20.90M | $22.88M | $15.62M | $27.86M | $48.26M | $18.31M | $18.09M | $51.24M |
| Net income | $18.86M | $17.06M | $11.56M | $27.02M | $21.86M | $26.74M | $18.20M | $82.77M | $50.99M | $23.82M | $23.70M | $55.16M |
Balance Sheet
As of Dec 2025, cash and equivalents exceeded short-term debt of $3.22M by $299.32M.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $766.43M | $785.67M | $863.29M | $644.41M | $478.54M | $295.76M | $218.38M | $81.06M | $39.44M | $16.49M |
| Current assets | $698.62M | $714.45M | $845.33M | $629.37M | $470.11M | $289.59M | $213.21M | $77.76M | $37.15M | $14.30M |
| Cash and equivalents | $302.54M | $155.33M | $144.41M | $97.54M | $68.14M | $68.94M | $44.73M | $24.72M | $17.59M | $6.70M |
| Total liabilities | $83.23M | $81.85M | $75.91M | $89.79M | $62.74M | $40.29M | $38.58M | $36.38M | $19.99M | $7.37M |
| Short-term debt | $3.22M | $2.51M | $2.40M | $1.45M | $1.21M | $880.00K | $672.00K | $324.00K | $3.02M | N/A |
| Shareholder equity | $683.20M | $703.81M | $787.37M | $554.62M | $415.80M | $253.96M | $176.07M | $43.26M | $19.45M | $8.92M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $740.48M | $720.33M | $750.84M | $766.43M | $734.61M | $708.35M | $704.74M | $785.67M | $824.03M | $859.84M | $891.74M | $863.29M |
| Total liabilities | $89.26M | $91.20M | $89.58M | $83.23M | $81.22M | $79.91M | $85.31M | $81.85M | $87.14M | $108.72M | $76.30M | $75.91M |
| Cash and equivalents | $397.11M | $396.17M | $394.30M | $302.54M | $252.44M | $216.24M | $145.95M | $155.33M | $164.84M | $92.00M | $120.93M | $144.41M |
| Shareholder equity | $651.22M | $629.13M | $661.25M | $683.20M | $653.38M | $628.44M | $619.43M | $703.81M | $736.89M | $751.12M | $815.43M | $787.37M |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 98.9% of operating cash flow.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $85.26M | $132.66M | $176.83M | $181.58M | $174.88M | $79.22M | $62.21M | $36.89M | $14.61M | $3.00M |
| Capital expenditures | $972.00K | $669.00K | $705.00K | $1.57M | $939.00K | $463.00K | $693.00K | $381.00K | $189.00K | $188.00K |
| Free cash flow | $84.28M | $132.00M | $176.12M | $180.00M | $173.95M | $78.76M | $61.51M | $36.51M | $14.42M | $2.81M |
| Investing cash flow | $186.03M | $162.21M | -$136.06M | -$109.47M | -$160.11M | -$43.30M | -$112.45M | -$29.74M | -$5.68M | -$426.00K |
| Financing cash flow | -$126.06M | -$282.77M | $5.50M | -$41.09M | -$15.02M | -$12.44M | $70.17M | $186.00K | $1.78M | $53.00K |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11.38M | $21.05M | $15.39M | $24.99M | $27.14M | $24.26M | $14.04M | $32.44M | $34.05M | $42.06M | $24.11M | $58.71M |
| Capital expenditures | $195.00K | $211.00K | $172.00K | $572.92K | $152.53K | $220.47K | $85.00K | $235.62K | $78.25K | $246.00K | $112.00K | $17.83K |
| Free cash flow | $11.19M | $20.84M | $15.21M | $24.41M | $26.99M | $24.04M | $13.96M | $32.21M | $33.97M | $41.81M | $24.00M | $58.69M |
Frequently Asked Questions About INMD
What is InMode's annual revenue?
InMode reported revenue of $370.50M for the fiscal year ended Dec 31, 2025.
How fast is InMode's revenue growing?
Revenue was down 6.2% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -6.6%.
Is InMode profitable?
Yes. InMode reported net income of $93.83M for the fiscal year ended Dec 31, 2025, with a net margin of 25.3%.
How much free cash flow does INMD generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $85.26M minus capital expenditures of $972.00K produced free cash flow of $84.28M.
How much debt does InMode have?
The balance sheet dated Dec 31, 2025 reported short-term debt of $3.22M and cash and equivalents of $302.54M.
INMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors